Breast Cancer Now
Elsevier and Breast Cancer Now have entered into an agreement which ensures authors publishing in Elsevier journals are compliant with their open access policy.
Breast Cancer Now requires electronic copies of any research articles that have been accepted for publication in a peer-reviewed journal, to be deposited in Europe PubMed Central (Europe PMC) as soon as possible and no later than 12 months after publication. Breast Cancer Now’s policy supports the green open access model, though gold open access remains a compliant option too. Read herethe open access policy of Breast Cancer Now.
Authors funded by Breast Cancer Now and publishing with Elsevier can comply with the policy in the following ways:
Green open access
- Authors publishing under the subscription model will need to keep a copy of their accepted manuscript (AM) and self-archive this in Europe PMC
- AMs can be made available publicly after the journal specific embargo period
- Authors should ensure a CC-BY-NC-ND license is attached to the accepted manuscript and that there is a link back to the final version of the article hosted on ScienceDirect, via its DOI, so their article can be cited. Please see our sharing policy for more information on how to do this
Gold open access
- Authors can choose to publish gold open access in Elsevier’s open access or hybrid journals
- When publishing open access, the corresponding author will be given a choice of two Creative Commons licenses
- An article publication charge (APC) is required to be paid in order to make an article open access. Elsevier's APCs range between c$150 and c$5,000 US Dollars excluding tax and are journal specific; please refer to the guide for authors on the journal homepage
- Authors can self-archive the final article in Europe PMC. Articles should contain a CrossMark logo, the end user license and a DOI link to the formal publication on ScienceDirect. Please see our sharing policy for more information on how to do this